Neuralink closed its $650 million Series E round in June 2025 at a post-money valuation of approximately $9.65 billion, more than doubling its prior $3.5 billion mark from late 2023 and providing substantial runway for clinical expansion. Secondary market activity has since driven implied valuations significantly higher, with one platform showing shares trading at levels consistent with roughly $47 billion as of May 2026 amid $2.9 billion in recent bids and offers. Ongoing human trials, including FDA Breakthrough Device designations for speech and vision restoration, alongside plans for high-volume device production in 2026, have supported investor interest in the brain-computer interface space. No new primary funding round or IPO has been announced, leaving near-term valuation shifts dependent on secondary trading volume and any regulatory or trial milestones before June 30.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-updateWill Neuralink’s valuation hit __ by June 30?
Will Neuralink’s valuation hit __ by June 30?
Current Valuation:$46.4B
+320.47%Powered by
$34,372 Vol.
Jul 1, 2026
↑$75B
11%
↑$50B
54%
↓$37.5B
13%
↓$35B
11%
↓$32.5B
2%
Current Valuation:$46.4B
+320.47%Powered by
$34,372 Vol.
↑$75B
$765 Vol.
11%
↑$50B
$467 Vol.
54%
↓$37.5B
$2,476 Vol.
13%
↓$35B
$2,750 Vol.
11%
↓$32.5B
$4,374 Vol.
2%
This market will resolve to "Yes" if Neuralink's private market valuation, as measured by the NPM Price reported by Nasdaq Private Market, LLC (NPM) for any date between market creation and June 30, 2026, reaches or exceeds the listed amount. Otherwise, this market will resolve to "No".
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on July 1, 2026, this market may remain open until 11:59 PM ET on July 4, 2026. If no further data is released by that time, the market will resolve according to the data available.
If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.
If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company's public market capitalization between the IPO or direct listing date and the end of the specified period.
Public market capitalization will be determined using the highest/lowest official regular-hours trading price published for the company's primary listed common equity on its primary exchange for any trading day during the specified period, multiplied by the company's total outstanding common shares at the relevant time.
If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-802a7f97-3625-4614-a13d-d999cf139330/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.Neuralink closed its $650 million Series E round in June 2025 at a post-money valuation of approximately $9.65 billion, more than doubling its prior $3.5 billion mark from late 2023 and providing substantial runway for clinical expansion. Secondary market activity has since driven implied valuations significantly higher, with one platform showing shares trading at levels consistent with roughly $47 billion as of May 2026 amid $2.9 billion in recent bids and offers. Ongoing human trials, including FDA Breakthrough Device designations for speech and vision restoration, alongside plans for high-volume device production in 2026, have supported investor interest in the brain-computer interface space. No new primary funding round or IPO has been announced, leaving near-term valuation shifts dependent on secondary trading volume and any regulatory or trial milestones before June 30.
This market will resolve to "Yes" if Neuralink's private market valuation, as measured by the NPM Price reported by Nasdaq Private Market, LLC (NPM) for any date between market creation and June 30, 2026, reaches or exceeds the listed amount. Otherwise, this market will resolve to "No".
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on July 1, 2026, this market may remain open until 11:59 PM ET on July 4, 2026. If no further data is released by that time, the market will resolve according to the data available.
If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.
If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company's public market capitalization between the IPO or direct listing date and the end of the specified period.
Public market capitalization will be determined using the highest/lowest official regular-hours trading price published for the company's primary listed common equity on its primary exchange for any trading day during the specified period, multiplied by the company's total outstanding common shares at the relevant time.
If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-802a7f97-3625-4614-a13d-d999cf139330/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on July 1, 2026, this market may remain open until 11:59 PM ET on July 4, 2026. If no further data is released by that time, the market will resolve according to the data available.
If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.
If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company's public market capitalization between the IPO or direct listing date and the end of the specified period.
Public market capitalization will be determined using the highest/lowest official regular-hours trading price published for the company's primary listed common equity on its primary exchange for any trading day during the specified period, multiplied by the company's total outstanding common shares at the relevant time.
If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-802a7f97-3625-4614-a13d-d999cf139330/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
Binuksan ang Market: May 19, 2026, 12:38 AM ET
Volume
$34,372Petsa ng Pagtatapos
Jul 1, 2026Binuksan ang Market
May 19, 2026, 12:38 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if Neuralink's private market valuation, as measured by the NPM Price reported by Nasdaq Private Market, LLC (NPM) for any date between market creation and June 30, 2026, reaches or exceeds the listed amount. Otherwise, this market will resolve to "No".
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on July 1, 2026, this market may remain open until 11:59 PM ET on July 4, 2026. If no further data is released by that time, the market will resolve according to the data available.
If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.
If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company's public market capitalization between the IPO or direct listing date and the end of the specified period.
Public market capitalization will be determined using the highest/lowest official regular-hours trading price published for the company's primary listed common equity on its primary exchange for any trading day during the specified period, multiplied by the company's total outstanding common shares at the relevant time.
If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-802a7f97-3625-4614-a13d-d999cf139330/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.Neuralink closed its $650 million Series E round in June 2025 at a post-money valuation of approximately $9.65 billion, more than doubling its prior $3.5 billion mark from late 2023 and providing substantial runway for clinical expansion. Secondary market activity has since driven implied valuations significantly higher, with one platform showing shares trading at levels consistent with roughly $47 billion as of May 2026 amid $2.9 billion in recent bids and offers. Ongoing human trials, including FDA Breakthrough Device designations for speech and vision restoration, alongside plans for high-volume device production in 2026, have supported investor interest in the brain-computer interface space. No new primary funding round or IPO has been announced, leaving near-term valuation shifts dependent on secondary trading volume and any regulatory or trial milestones before June 30.
This market will resolve to "Yes" if Neuralink's private market valuation, as measured by the NPM Price reported by Nasdaq Private Market, LLC (NPM) for any date between market creation and June 30, 2026, reaches or exceeds the listed amount. Otherwise, this market will resolve to "No".
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on July 1, 2026, this market may remain open until 11:59 PM ET on July 4, 2026. If no further data is released by that time, the market will resolve according to the data available.
If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.
If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company's public market capitalization between the IPO or direct listing date and the end of the specified period.
Public market capitalization will be determined using the highest/lowest official regular-hours trading price published for the company's primary listed common equity on its primary exchange for any trading day during the specified period, multiplied by the company's total outstanding common shares at the relevant time.
If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-802a7f97-3625-4614-a13d-d999cf139330/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on July 1, 2026, this market may remain open until 11:59 PM ET on July 4, 2026. If no further data is released by that time, the market will resolve according to the data available.
If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.
If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company's public market capitalization between the IPO or direct listing date and the end of the specified period.
Public market capitalization will be determined using the highest/lowest official regular-hours trading price published for the company's primary listed common equity on its primary exchange for any trading day during the specified period, multiplied by the company's total outstanding common shares at the relevant time.
If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-802a7f97-3625-4614-a13d-d999cf139330/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
Volume
$34,372Petsa ng Pagtatapos
Jul 1, 2026Binuksan ang Market
May 19, 2026, 12:38 AM ETResolver
0x65070BE91...Neuralink closed its $650 million Series E round in June 2025 at a post-money valuation of approximately $9.65 billion, more than doubling its prior $3.5 billion mark from late 2023 and providing substantial runway for clinical expansion. Secondary market activity has since driven implied valuations significantly higher, with one platform showing shares trading at levels consistent with roughly $47 billion as of May 2026 amid $2.9 billion in recent bids and offers. Ongoing human trials, including FDA Breakthrough Device designations for speech and vision restoration, alongside plans for high-volume device production in 2026, have supported investor interest in the brain-computer interface space. No new primary funding round or IPO has been announced, leaving near-term valuation shifts dependent on secondary trading volume and any regulatory or trial milestones before June 30.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-update
Mag-ingat sa mga external link.
Mag-ingat sa mga external link.
Mga Madalas na Tanong